Pediatrics CME topics for 2026: what to focus on (and what can wait)
Pediatrics CME topics for 2026: the vaccine schedule split, RSV, a new UTI guideline, infant care updates, teen mental health and a 3-day study plan.
Editorial source check: October 8, 2026. This study-planning overview is not a clinical guideline or independent clinical review.
Pediatricians had a year. Two national immunization schedules, a federal court ruling, a brand-new UTI guideline, a new name for failure to thrive, record measles numbers, and a policy statement that politely declares the "screen time limit" conversation too small. Meanwhile, your inbox still holds the 2026–2027 flu statement you meant to read in August.
For a study plan covering the rest of 2026 and early 2027, start with these topics:
- Immunizations: the AAP–CDC schedule split, RSV prevention, and the measles resurgence
- Newborns and infants: congenital CMV, faltering weight, iron deficiency and early food introduction
- Acute care: the 2026 UTI guideline and office emergency readiness
- Adolescent and behavioral health: mental health screening, digital media, nicotine and injury prevention
- MOCA-Peds: the featured readings that tell you what your peers think everyone should read
Below: what changed, where to read it, and what can wait.
Before booking an activity, check your state CME requirements and specialty board requirements. The ABP's MOC requirements are distinct from a state license's CME hours.
What are the most important pediatrics CME topics in 2026?
| Topic | What changed | Key document (date) |
|---|---|---|
| Immunization schedule | AAP and CDC schedules diverged; a court stayed the federal changes | AAP 2026 schedule (Jan. 26, 2026); HHS/CDC change (Jan. 5, 2026) |
| RSV, COVID-19, influenza | Updated AAP seasonal statements; RSV second-season high-risk criteria expanded | AAP RSV and COVID-19 statements (Sept. 2, 2026); influenza (Aug. 10, 2026) |
| Urinary tract infection | First update since 2011; ages 8 days to 5 years | AAP UTI guideline (Sept. 28, 2026) |
| Faltering weight | Replaces "failure to thrive"; z score criteria | AAP/NASPGHAN guideline (March 16, 2026) |
| Newborn and infant | Congenital CMV; iron deficiency | cCMV report (Sept. 21, 2026); iron report (June 22, 2026) |
| Mental health and media | Screening from infancy; a broader digital-media framework | MEB screening report (Aug. 25, 2025); Digital Ecosystems (Jan. 20, 2026) |
This post summarizes published documents for study planning; it is not clinical advice. Read the full document before changing practice.
Why should immunizations top your list?
Because "per the schedule" now needs a follow-up question: which schedule?
Two schedules and a court case
On Jan. 5, 2026, the CDC's acting director signed a decision memo that reorganized the childhood schedule into three tiers. Vaccines against 11 diseases stayed recommended for all children; RSV, hepatitis A and B, rotavirus, COVID-19, influenza and meningococcal vaccines moved to high-risk or shared clinical decision-making categories. That followed a December 2025 change to the hepatitis B birth dose for infants of mothers who test negative.
On Jan. 26, the AAP released its own 2026 schedule, keeping routine protection against 18 diseases, with endorsements from 12 medical organizations. Then, on March 16, a federal judge in Massachusetts stayed the January changes, the appointments of 13 ACIP members and that committee's votes. The government appealed to the First Circuit; check the latest orders for the current procedural status (case tracker).
Study tip: Put the CDC schedule page and the AAP schedule side by side, and know which one your state, payers and school-entry rules follow. Then check the case status again before you counsel from memory. This one moves.
RSV: more options, more nuance
The FDA approved a second infant monoclonal antibody, clesrovimab (Enflonsia), on June 9, 2025, joining nirsevimab and the maternal vaccine. The AAP's Sept. 2, 2026 RSV statement recommends immunization for infants under 8 months in their first season unless they're protected by maternal vaccination, and it expands the high-risk criteria for children 8 through 19 months entering a second season. The same day brought the AAP's 2026–2027 COVID-19 statement; the 2026–2027 influenza statement arrived Aug. 10.
Measles and pertussis are not history lessons
The CDC counted 3,887 confirmed measles cases in 2026 as of Oct. 1, after 2,289 in all of 2025, with 42 new outbreaks and two deaths this year. For elimination-status updates, consult PAHO; review timing is separate from a formal decision. Pertussis surged in 2024 (more than six times 2023's count) and is running lower in 2026, but infants still carry the highest risk. If a febrile rash hasn't crossed your mind in a while, a measles refresher is cheap insurance.
What's new for newborns and infants?
- Congenital CMV. A Sept. 21, 2026 clinical report builds on the Red Book, reviews diagnosis, initial evaluation and treatment, and recommends hearing-targeted plus expanded screening.
- Faltering weight. The AAP/NASPGHAN guideline (March 16, 2026) retires "failure to thrive," defines faltering weight with z score cutoffs instead of percentiles, and was built with GRADE. It's the AAP's methods shift in action, explained in "AAP's Transition to GRADE" (May 6, 2026).
- Iron deficiency. A June 22, 2026 clinical report covers prevention, updated screening, diagnosis and oral and intravenous treatment options from birth through adolescence, including heavy menstrual bleeding.
- Early food introduction. A 2025 Pediatrics study found peanut and overall IgE-mediated food allergy incidence fell after the 2015 and 2017 early-introduction guidance. Nice to have data behind the "peanut talk."
- Lead. The FDA finalized action levels for lead in baby foods in January 2025; the CDC's blood lead reference value remains 3.5 µg/dL.
Which acute-care updates matter in clinic, urgent care and the hospital?
The headline is the AAP UTI guideline, published Sept. 28, 2026. It replaces the 2011 guideline and widens the age range to 8 days through 5 years. It has 8 key action statements (2 strong, 6 conditional) and 4 good practice statements covering evaluation, antibiotic management and imaging. A companion technical report revises the UTI definition, with pyuria thresholds by age and culture thresholds by age and collection method. If you see febrile infants anywhere (office, urgent care, ED or the wards), read this one first.
Also worth an evening:
- Preparation for Pediatric Emergencies in the Office (April 20, 2026), the first update since 2007, with a readiness checklist
- Pediatric Readiness in the Emergency Department (Jan. 20, 2026), a joint AAP/ACEP/ACS/ENA statement
- Nonemergency Acute Care Delivered Outside of the Medical Home (May 18, 2026), on urgent care, retail clinics and telehealth
What should adolescent and behavioral health CME cover?
Mental health screening, from infancy up
The AAP's August 2025 clinical report on mental health, emotional and behavioral screening starts with caregiver postpartum depression screening in the first month and child-focused screening from 6 months. The Bright Futures periodicity schedule keeps depression and suicide risk screening for adolescents, with attention to confidentiality. An April 2026 clinical report reframes mental and emotional development as part of whole health rather than a diagnosis to rush toward.
Digital media, beyond the timer
The AAP's Digital Ecosystems policy statement (Jan. 20, 2026) argues that media can't be viewed "solely through the lens of individual child behaviors or screen limits." It looks at children, caregivers, platform design and policy together. Expect the family-media conversation to shift from minutes to design, sleep and displacement.
Nicotine, substances and injury
- Vaping: the 2025 National Youth Tobacco Survey (published June 2026) found 5.2% of middle and high school students currently use e-cigarettes and 1.7% use nicotine pouches. The American Thoracic Society's 2025 guideline on treating nicotine use in adolescents is a focused source to consider for an adolescent-health study day.
- Opioids: the periodicity schedule's substance-use footnote points to naloxone resources; pair it with the AAP's 2024 outpatient opioid prescribing guideline, a focused source for outpatient prescribing study.
- Firearms and sports: Counseling on firearm safety and managing concussion are useful study themes. The AAP's firearm policy statement and the Amsterdam concussion consensus remain the core reads.
- Obesity pharmacotherapy: "GLP-1 Receptor Agonists in Pediatric and Adolescent Obesity" is a review to consider alongside current pediatric obesity guidance.
How does MOCA-Peds shape your reading list?
Use ABP's MOCA-Peds FAQs, 2026 content and 2027 content page to check your current assessment format, learning objectives and featured readings. Treat preliminary lists as provisional. Read the official materials alongside the clinical documents above; this post does not predict questions or certify that a paper remains on a featured-reading list.
Which pediatric updates can wait (or are still moving)?
- 2027 MOCA-Peds content: check the ABP exam-content page for final learning objectives and featured readings before locking your plan.
- U.S. measles elimination status: follow updates from PAHO rather than treating a reported review date as a confirmed decision.
- The schedule litigation: check the latest court orders and CDC schedule when planning your reading. An appeal or scheduled argument is not itself a change in recommendations.
- The next Red Book: the current edition is labeled 2024–2027. Wait for the new one before re-memorizing ID tables.
- Generative AI in pediatric care: an AAP policy statement appeared Oct. 3, 2026. Important, but unlikely to change Monday's clinic.
Targets slip, so treat every date above as a target, not a promise.
What does a 3-day pediatrics study plan look like?
Here is an illustrative plan using 9:00 AM–2:00 PM study days, with time after 2:00 PM free:
| Day | Theme | Reading focus |
|---|---|---|
| Day 1 | Newborn and infant | Congenital CMV report; faltering weight guideline; iron deficiency report; early food introduction study |
| Day 2 | Immunizations and infectious disease | AAP 2026 schedule vs. CDC page; RSV, COVID-19 and influenza statements; UTI guideline and technical report; measles refresher |
| Day 3 | Adolescent and behavioral health | MEB screening report; Digital Ecosystems statement; ATS nicotine guideline; MOCA-Peds featured readings |
End each day with three lines: what I read, what surprised me, what I might do differently.
Where does Shift CME fit in?
If the hard part is protecting the time rather than finding the papers, here's how Shift CME works. You plan a self-directed conference at a destination you choose from our list, every day of your dates including weekends, with journal modules chosen for your specialty (say, RSV prevention and adolescent mental health). Study days run 9:00 AM–2:00 PM local time, and time after 2:00 PM is yours. That's handy if you'd like to bring the kids. (Do not assume accompanying family members' travel costs qualify for a business deduction; ask your tax adviser.)
When you confirm, you get a confirmation PDF, dated that day, listing your program, venue and study days. A simple check-in from your phone confirms you're at your destination. After your last study day, we email your conference records and keep them together in Records. Knowledge checks and evaluations are optional unless required for the AMA CME credit you choose to claim.
These records are useful for a CME allowance request (see how to use your CME allowance) or, if you're self-employed, for your tax adviser. This isn't tax advice.
It depends on the session. A presentation or journal module offers AMA PRA Category 1 Credit™ only where its accredited provider offers a CME activity and supplies instructions for claiming it; then you claim it as that provider directs. That credit comes from the provider, not from Shift CME, and not every session offers it. Physicians may also self-claim AMA PRA Category 2 Credit™ for learning they judge meets the AMA's requirements, and your Shift CME records can support that claim. Nurse practitioners and physician assistants follow their own certifying bodies' rules: NCCPA lets PAs self-claim Category 2 CME, while AANPCB and ANCC require accredited contact hours, which Shift CME does not award. ABP MOC points come from ABP-approved activities. For ideas, see our Category 2 CME examples and year-end CME checklist.
Frequently asked questions
What are the top pediatrics CME topics for 2026?
Immunizations (the AAP–CDC schedule situation, RSV and measles), the new UTI and faltering weight guidelines, infant care (cCMV and iron deficiency), and adolescent mental health, digital media and nicotine.
Are the AAP and CDC immunization schedules the same in 2026?
No. The AAP's 2026 schedule keeps routine vaccination against 18 diseases. The CDC's January 2026 changes narrowed routine recommendations, but a federal court stayed them in March, and the government appealed. At this editorial check, the CDC schedule displays the July 2, 2025 addendum. Check both sources and the case status before relying on either.
Does reading guidelines count toward CME?
Under AMA rules, you may be able to self-claim AMA PRA Category 2 Credit for qualifying reading; whether it qualifies is your determination, and you keep the record. Whether it meets your state or board requirements is a separate question, so check with them.
Does Shift CME help with MOCA-Peds?
Focused reading of the featured readings and learning objectives can help you prepare. Shift CME is not ABP-approved preparation and does not award MOC points.
Sources
- HHS: CDC Acts on Presidential Memorandum to Update Childhood Immunization Schedule (Jan. 5, 2026)
- HHS: CDC Adopts Individual-Based Decision-Making for Hepatitis B Immunization (December 2025)
- HealthyChildren.org (AAP): AAP's Recommended Childhood and Adolescent Immunization Schedule for 2026
- Pediatrics: Recommended Childhood and Adolescent Immunization Schedule: United States, 2026: Policy Statement
- CDC: Child and Adolescent Immunization Schedule by Age
- APHA: Federal Judge Blocks Immunization Schedule Changes, Stays ACIP Member Appointments (March 16, 2026)
- Georgetown Health Care Litigation Tracker: American Academy of Pediatrics et al. v. Kennedy et al.
- Merck: U.S. FDA Approves Enflonsia (clesrovimab-cfor) (June 9, 2025)
- Pediatrics: Recommendations for the Prevention of RSV Disease in Infants and Children: Policy Statement (2026)
- Pediatrics: Recommendations for COVID-19 Vaccines in Infants, Children, and Adolescents, 2026–2027: Policy Statement
- Pediatrics: Recommendations for Prevention and Control of Influenza in Children, 2026–2027: Policy Statement
- CDC: Measles Cases and Outbreaks
- CIDRAP: US "highly likely" to lose measles elimination status this fall
- CDC: Pertussis Surveillance and Trends
- Pediatrics: Care of the Infant With Congenital Cytomegalovirus Infection: Clinical Report (2026)
- Pediatrics: Clinical Practice Guideline for Diagnosis and Management of Faltering Weight (2026)
- Pediatrics: AAP's Transition to GRADE for Clinical Practice Guidelines (2026)
- Pediatrics: Prevention, Screening, Diagnosis, and Treatment of Iron Deficiency and Iron Deficiency Anemia: Clinical Report (2026)
- Pediatrics: Guidelines for Early Food Introduction and Patterns of Food Allergy (2025)
- FDA: Action Levels for Lead in Processed Food Intended for Babies and Young Children (January 2025)
- CDC: CDC Updates Blood Lead Reference Value
- Pediatrics: Clinical Practice Guideline for the Diagnosis and Treatment of UTI in Children From 8 Days to 5 Years of Age (2026)
- Pediatrics: Urinary Tract Infection Diagnosis: Technical Report (2026)
- Pediatrics: Preparation for Pediatric Emergencies in the Office: Policy Statement (2026)
- Pediatrics: Pediatric Readiness in the Emergency Department: Policy Statement (2026)
- Pediatrics: Nonemergency Acute Care Delivered Outside of the Medical Home: Policy Statement (2026)
- Pediatrics: Promoting Optimal Development: Screening for Mental Health, Emotional, and Behavioral Problems: Clinical Report (2025)
- Pediatrics: Framework for Approaching Healthy Mental and Emotional Development in Pediatrics: Clinical Report (2026)
- AAP/Bright Futures: Recommendations for Preventive Pediatric Health Care (Periodicity Schedule, updated February 2025)
- Pediatrics: Digital Ecosystems, Children, and Adolescents: Policy Statement (2026)
- Nicotine & Tobacco Research: Tobacco Product Use Among Middle and High School Students: National Youth Tobacco Survey, 2025
- AJRCCM: Treatment of Nicotine Use in Adolescents Under 18 Years of Age: ATS Clinical Practice Guideline (2025)
- Pediatrics: Opioid Prescribing for Acute Pain Management in Children and Adolescents in Outpatient Settings: Clinical Practice Guideline (2024)
- Pediatrics: Firearm-Related Injuries and Deaths in Children and Youth (2022)
- BJSM: Consensus Statement on Concussion in Sport, Amsterdam 2022
- Pediatrics: GLP-1 Receptor Agonists in Pediatric and Adolescent Obesity (2025)
- Pediatrics: Genetic Evaluation of the Child With Intellectual Disability or Global Developmental Delay: Clinical Report (2025)
- Pediatrics: Recommendations for Generative AI Tools in Pediatric Clinical Care: Policy Statement (2026)
- ABP: MOCA-Peds FAQs
- ABP: 2026 MOCA-Peds Exam Content
- ABP: 2027 MOCA-Peds Exam Content (preliminary)
- AMA: What to know about the other kind of CME credit
Make room for your next question
Plan a pediatrics conference around the questions your patients keep asking. Membership is $999 a year (introductory price), plus applicable tax, or $349 for a single conference.
Travel, accommodation and external learning costs are separate. Shift CME does not guarantee reimbursement, tax benefits or acceptance of a record.